PL2575467T3 - Związki makrocykliczne użyteczne jako inhibitory deacetylaz histonowych - Google Patents
Związki makrocykliczne użyteczne jako inhibitory deacetylaz histonowychInfo
- Publication number
- PL2575467T3 PL2575467T3 PL11787462T PL11787462T PL2575467T3 PL 2575467 T3 PL2575467 T3 PL 2575467T3 PL 11787462 T PL11787462 T PL 11787462T PL 11787462 T PL11787462 T PL 11787462T PL 2575467 T3 PL2575467 T3 PL 2575467T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- compounds useful
- histone deacetylases
- macrocyclic compounds
- macrocyclic
- Prior art date
Links
- 102000003964 Histone deacetylase Human genes 0.000 title 1
- 108090000353 Histone deacetylase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000002678 macrocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34897810P | 2010-05-27 | 2010-05-27 | |
| EP11787462.8A EP2575467B1 (en) | 2010-05-27 | 2011-05-26 | Macrocyclic compounds useful as inhibitors of histone deacetylases |
| PCT/US2011/038246 WO2011150283A1 (en) | 2010-05-27 | 2011-05-26 | Macrocyclic compounds useful as inhibitors of histone deacetylases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2575467T3 true PL2575467T3 (pl) | 2017-10-31 |
Family
ID=45004403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11787462T PL2575467T3 (pl) | 2010-05-27 | 2011-05-26 | Związki makrocykliczne użyteczne jako inhibitory deacetylaz histonowych |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8754050B2 (pl) |
| EP (1) | EP2575467B1 (pl) |
| JP (1) | JP5931850B2 (pl) |
| KR (2) | KR102028850B1 (pl) |
| CN (1) | CN102946732B (pl) |
| AU (1) | AU2011258110B2 (pl) |
| BR (1) | BR112012030193B1 (pl) |
| CA (1) | CA2800958C (pl) |
| DK (1) | DK2575467T3 (pl) |
| ES (1) | ES2594500T3 (pl) |
| HK (1) | HK1181613A1 (pl) |
| HU (1) | HUE030812T2 (pl) |
| LT (1) | LT2575467T (pl) |
| MX (1) | MX2012013507A (pl) |
| PL (1) | PL2575467T3 (pl) |
| PT (1) | PT2575467T (pl) |
| RU (1) | RU2565076C2 (pl) |
| WO (1) | WO2011150283A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102391359B (zh) * | 2011-11-17 | 2014-07-16 | 南京优科生物医药研究有限公司 | 组蛋白去乙酰化酶抑制剂及其合成方法和制药用途 |
| CN103232474A (zh) * | 2013-04-16 | 2013-08-07 | 中国药科大学 | 组蛋白去乙酰化酶抑制剂 |
| CN106800589B (zh) * | 2013-09-02 | 2021-01-12 | 李铁旦 | 一类环肽类化合物、其制备方法、药物组合物及用途 |
| DK3578179T3 (da) * | 2014-05-27 | 2021-03-15 | Onkure Inc | Process for the preparation of cyclic depsipeptides |
| JP6785801B2 (ja) * | 2015-03-06 | 2020-11-18 | コロラド ステート ユニバーシティー リサーチ ファウンデーション | 新しいキャップ基ラルガゾールの類似体の合成及び使用 |
| CA2978698A1 (en) | 2015-03-06 | 2016-09-15 | Colorado State University Research Foundation | Method for preparing largazole analogs and uses thereof |
| CN105131082A (zh) * | 2015-09-17 | 2015-12-09 | 广州康缔安生物科技有限公司 | 环肽类化合物及其应用 |
| CN106674252B (zh) * | 2015-11-11 | 2019-10-29 | 复旦大学 | 海洋天然产物环酯肽的氟代烯烃类似物、其制备方法和用途 |
| JP6691958B2 (ja) * | 2016-05-20 | 2020-05-13 | オンキュアー，インコーポレイテッド | ヒストンデアセチラーゼの阻害剤としての大環状分子のチオエステルプロドラッグ |
| CN107286223B (zh) * | 2017-07-17 | 2019-12-20 | 湖北大学 | 一种用于检测组蛋白位点乙酰化的重组蛋白及其应用 |
| CN111269245B (zh) * | 2018-12-04 | 2021-08-27 | 杭州百新生物医药科技有限公司 | 一种环状氨基嘧啶衍生物及其抑制激酶的活性和用途 |
| US20220017520A1 (en) * | 2018-12-19 | 2022-01-20 | Keythera (Suzhou) Pharmaceuticals Co. Ltd. | Macrocyclic compound as cdk inhibitor, preparation method therefor, and use thereof in medicine |
| EP3941457A4 (en) | 2019-03-21 | 2023-04-26 | Merck Sharp & Dohme LLC | HISTONE-DEACETYLASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF HIV INFECTION |
| KR102436309B1 (ko) * | 2020-05-26 | 2022-08-25 | 연세대학교 산학협력단 | 암의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8920304D0 (en) | 1989-09-08 | 1989-10-25 | Fujisawa Pharmaceutical Co | Fr901375 substance and preparation thereof |
| US7098186B2 (en) * | 2002-08-30 | 2006-08-29 | Astellas Pharma Inc | Depsipeptide compound |
| KR20050074547A (ko) * | 2002-11-12 | 2005-07-18 | 알콘, 인코퍼레이티드 | 눈의 퇴행성 질환을 치료하기 위한 히스톤 디아세틸라제저해제 |
| US20060128660A1 (en) * | 2004-12-10 | 2006-06-15 | Wisconsin Alumni Research Foundation | FK228 analogs and methods of making and using the same |
| US8865655B2 (en) * | 2006-11-22 | 2014-10-21 | Karus Therapeutics Limited | Depsipeptides and their therapeutic use |
| GB0623388D0 (en) * | 2006-11-23 | 2007-01-03 | Univ Southampton | Chemical compounds |
| GB0715750D0 (en) * | 2007-08-13 | 2007-09-19 | Karus Therapeutics Ltd | Chemical compounds |
| EP2276757B1 (en) * | 2008-04-11 | 2016-01-06 | University of Florida Research Foundation, Inc. | Macrocyclic compounds and methods of treatment |
| US8217076B2 (en) * | 2008-07-17 | 2012-07-10 | Colorado State University Research Foundation | Method for preparing largazole analogs and uses thereof |
| CN102391359B (zh) * | 2011-11-17 | 2014-07-16 | 南京优科生物医药研究有限公司 | 组蛋白去乙酰化酶抑制剂及其合成方法和制药用途 |
-
2011
- 2011-05-26 JP JP2013512261A patent/JP5931850B2/ja active Active
- 2011-05-26 CA CA2800958A patent/CA2800958C/en active Active
- 2011-05-26 RU RU2012157293/04A patent/RU2565076C2/ru active
- 2011-05-26 KR KR1020187018653A patent/KR102028850B1/ko active IP Right Grant
- 2011-05-26 AU AU2011258110A patent/AU2011258110B2/en active Active
- 2011-05-26 BR BR112012030193-4A patent/BR112012030193B1/pt active IP Right Grant
- 2011-05-26 MX MX2012013507A patent/MX2012013507A/es unknown
- 2011-05-26 EP EP11787462.8A patent/EP2575467B1/en active Active
- 2011-05-26 WO PCT/US2011/038246 patent/WO2011150283A1/en active Application Filing
- 2011-05-26 HU HUE11787462A patent/HUE030812T2/en unknown
- 2011-05-26 ES ES11787462.8T patent/ES2594500T3/es active Active
- 2011-05-26 DK DK11787462.8T patent/DK2575467T3/en active
- 2011-05-26 US US13/700,373 patent/US8754050B2/en active Active
- 2011-05-26 KR KR1020127033908A patent/KR20130123301A/ko active IP Right Grant
- 2011-05-26 PT PT117874628T patent/PT2575467T/pt unknown
- 2011-05-26 PL PL11787462T patent/PL2575467T3/pl unknown
- 2011-05-26 CN CN201180030608.3A patent/CN102946732B/zh active Active
- 2011-05-26 LT LTEP11787462.8T patent/LT2575467T/lt unknown
-
2013
- 2013-08-01 HK HK13108993.5A patent/HK1181613A1/xx unknown
-
2014
- 2014-05-29 US US14/289,877 patent/US9422340B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9422340B2 (en) | 2016-08-23 |
| WO2011150283A1 (en) | 2011-12-01 |
| AU2011258110A1 (en) | 2013-01-10 |
| EP2575467A1 (en) | 2013-04-10 |
| HUE030812T2 (en) | 2017-05-29 |
| US20130203681A1 (en) | 2013-08-08 |
| US20150010541A1 (en) | 2015-01-08 |
| CN102946732B (zh) | 2014-11-26 |
| MX2012013507A (es) | 2013-03-12 |
| PT2575467T (pt) | 2016-10-14 |
| BR112012030193B1 (pt) | 2020-11-17 |
| BR112012030193A2 (pt) | 2015-09-29 |
| AU2011258110B2 (en) | 2015-07-16 |
| KR102028850B1 (ko) | 2019-10-04 |
| CN102946732A (zh) | 2013-02-27 |
| CA2800958A1 (en) | 2011-12-01 |
| KR20130123301A (ko) | 2013-11-12 |
| ES2594500T3 (es) | 2016-12-20 |
| EP2575467B1 (en) | 2016-07-06 |
| RU2012157293A (ru) | 2014-07-10 |
| RU2565076C2 (ru) | 2015-10-20 |
| CA2800958C (en) | 2018-09-04 |
| HK1181613A1 (en) | 2013-11-15 |
| US8754050B2 (en) | 2014-06-17 |
| JP2013528182A (ja) | 2013-07-08 |
| KR20180081153A (ko) | 2018-07-13 |
| EP2575467A4 (en) | 2014-10-15 |
| DK2575467T3 (en) | 2016-09-26 |
| LT2575467T (lt) | 2017-01-10 |
| JP5931850B2 (ja) | 2016-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1259135A1 (zh) | Vmat2的苯並喹啉酮抑制劑 | |
| HK1181613A1 (en) | Macrocyclic compounds useful as inhibitors of histone deacetylases | |
| ZA201707157B (en) | Multisubsituted aromatic compounds as inhibitors of thrombin | |
| ZA201700326B (en) | Inhibitors of beta-secretase | |
| IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
| EP2701699A4 (en) | INHIBITORS OF HISTONE DEACETYLASE | |
| HK1176616A1 (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 cdk4/6 | |
| HK1178149A1 (en) | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4--- | |
| IL221823A (en) | Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors | |
| EP2584903A4 (en) | NEW HETEROCYCLIC COMPOUNDS AS ERK HEMMER | |
| PL3255114T5 (pl) | Zastosowanie kompozycji do chłodzenia | |
| EP2539348A4 (en) | CEPHALOSPORIN DERIVATIVES AS BETA LACTAMASE HEMMER AND COMPOSITIONS THEREFOR AND METHOD FOR THEIR USE | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| IL218018A0 (en) | Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions | |
| ZA201208895B (en) | Bicyclic compound derivatives and their use as acc inhibitors | |
| SG2014013460A (en) | Monohydrate of an azaadamantane derivative | |
| IL222313A0 (en) | Combination of organic compounds | |
| EP2531197A4 (en) | SOLID FORMS OF MACROCYCLIC CHINESE INHIBITORS | |
| EP2579872A4 (en) | HAMMER OF ACT ACTIVITY | |
| IL225708A0 (en) | Methods for the synthesis of scylitol and related compounds | |
| GB2492717B (en) | Detecting no progress state of an application | |
| EP2543373A4 (en) | PHARMACEUTICAL COMPOSITION OF LEVOAMLODIPINE COMPOUND | |
| LU91725B1 (en) | Novel uses of V-ATPASE inhibitors | |
| HK1160443A1 (en) | Histone deacetylase inhibitors | |
| GB201010671D0 (en) | Compounds for treatment of inflammation |